Self-management for Chronic Kidney Disease (CKD)

Phase-Based Progress Estimates
Iowa City VA Health Care System, Iowa City, IA, Iowa City, IA
Chronic Kidney Disease (CKD)+2 More
Self-management of BP medications - Behavioral
All Sexes
What conditions do you have?

Study Summary

The proposed research will evaluate if patients managing their blood pressure medications under the guidance of a clinical pharmacist works better to lower blood pressure than patients monitoring their blood pressure at home and the standard care. 60 Veterans with chronic kidney disease (CKD) will be included in the study. The study will further evaluate factors that may influence the Veteran to accept the self-management approach and what factors in the VHA healthcare system affect the implementation of the self-management approach.

Eligible Conditions

  • Chronic Kidney Disease (CKD)

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Other trials for Chronic Kidney Disease (CKD)

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 12 months

12 months
Change in conventional office BP
Change in standardized office BP
Change in standardized office diastolic BP
Home BP readings

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Other trials for Chronic Kidney Disease (CKD)

Trial Design

2 Treatment Groups

1 of 2
1 of 2
Active Control
Experimental Treatment

160 Total Participants · 2 Treatment Groups

Primary Treatment: Self-management · No Placebo Group · Phase 3

Experimental Group · 1 Intervention: Self-management of BP medications · Intervention Types: Behavioral
ActiveComparator Group · 1 Intervention: Self-monitoring of home BP · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months
Closest Location: Iowa City VA Health Care System, Iowa City, IA · Iowa City, IA
Photo of Iowa City  1Photo of Iowa City  2Photo of Iowa City  3
2007First Recorded Clinical Trial
1 TrialsResearching Chronic Kidney Disease (CKD)
21 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have CKD stage 3 or 4 (estimated GFR: 15-59 mL/min/1.73m2) or Stage 2 CKD (estimated GFR 60-89 mL/min/1.
You have uncontrolled hypertension defined as the avg of 2 readings > 140 systolic.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.